CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 126 filers reported holding CYTOKINETICS INC in Q4 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,013,289,000 | +19.8% | 69,882 | 0.0% | 0.09% | +10.3% |
| Q2 2017 | $845,572,000 | +224.3% | 69,882 | +244.4% | 0.08% | +200.0% |
| Q1 2017 | $260,714,000 | -38.6% | 20,289 | -54.6% | 0.03% | -55.2% |
| Q2 2016 | $424,393,000 | -77.8% | 44,720 | -83.5% | 0.06% | -78.3% |
| Q1 2016 | $1,914,287,000 | -23.8% | 271,530 | +13.1% | 0.27% | -29.0% |
| Q4 2015 | $2,512,105,000 | +133.6% | 240,163 | +49.4% | 0.38% | +70.9% |
| Q3 2015 | $1,075,531,000 | – | 160,767 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |